Who owns ABBOTT LABORATORIES?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of ABT from SEC Form 13F filings across 2,971 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 2,971 institutions disclosed 1.38B shares of ABBOTT LABORATORIES worth $125.10B — about 79.2% of shares outstanding; the largest disclosed holder is BlackRock, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.
2,971
13F holders
$125.10B
value, 2026 filers
79.2%
of shares outstanding (1.38B sh)
246
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of ABT's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 152.6M | $13.84B | 0.2% | 8.8% | +4.7% |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 113.8M | $10.32B | 0.2% | 6.5% | +0.7% |
| 3 | STATE STREET CORP | 80.9M | $7.34B | 0.2% | 4.6% | +1.7% |
| 4 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 59.7M | $5.41B | 0.7% | 3.4% | +31.2% |
| 5 | VANGUARD PORTFOLIO MANAGEMENT LLC | 49.0M | $4.45B | 0.2% | 2.8% | +2.2% |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 39.2M | $3.54B | 0.2% | 2.3% | +0.2% |
| 7 | Capital Research Global Investors | 36.9M | $3.35B | 0.5% | 2.1% | -25.8% |
| 8 | Capital International Investors | 34.7M | $3.15B | 0.7% | 2% | -7.6% |
| 9 | MORGAN STANLEY | 26.6M | $2.41B | 0.1% | 1.5% | -11.6% |
| 10 | NORGES BANKNEW | 23.4M | $2.12B | 0.2% | 1.3% | new |
| 11 | PRICE T ROWE ASSOCIATES INC /MD/ | 22.8M | $2.07B | 0.2% | 1.3% | +31.9% |
| 12 | FRANKLIN RESOURCES INC | 18.8M | $1.71B | 0.4% | 1.1% | -6.1% |
| 13 | NORTHERN TRUST CORP | 18.3M | $1.66B | 0.2% | 1% | -5.8% |
| 14 | BANK OF AMERICA CORP /DE/ | 17.7M | $1.60B | 0.1% | 1% | -8.3% |
| 15 | GOLDMAN SACHS GROUP INC | 16.8M | $1.52B | 0.1% | 1% | +15.5% |
| 16 | DEUTSCHE BANK AG\ | 16.7M | $1.52B | 0.4% | 1% | +18.6% |
| 17 | WELLS FARGO & COMPANY/MN | 15.2M | $1.38B | 0.2% | 0.9% | -4.6% |
| 18 | JPMORGAN CHASE & CO | 15.1M | $1.40B | 0.1% | 0.9% | -43.6% |
| 19 | STATE FARM MUTUAL AUTOMOBILE INSURANCE CO | 13.6M | $1.23B | 0.8% | 0.8% | 0.0% |
| 20 | FMR LLC | 13.4M | $1.22B | 0.1% | 0.8% | +23.8% |
| 21 | MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 13.4M | $1.22B | 0.4% | 0.8% | -13.8% |
| 22 | UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 12.8M | $1.16B | 0.2% | 0.7% | -2.8% |
| 23 | Legal & General Group Plc | 11.9M | $1.08B | 0.2% | 0.7% | -2.9% |
| 24 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 10.9M | $988.8M | 0.4% | 0.6% | +97.3% |
| 25 | AMERIPRISE FINANCIAL INC | 10.7M | $975.4M | 0.2% | 0.6% | -24.2% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.